Form 8-K - Current report:
SEC Accession No. 0001193125-25-203746
Filing Date
2025-09-15
Accepted
2025-09-15 17:01:20
Documents
14
Period of Report
2025-09-12
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d14130d8k.htm   iXBRL 8-K 29720
2 EX-3.1 d14130dex31.htm EX-3.1 7813
3 EX-3.2 d14130dex32.htm EX-3.2 8097
  Complete submission text file 0001193125-25-203746.txt   170301

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20250912.xsd EX-101.SCH 2839
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20250912_lab.xml EX-101.LAB 18721
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20250912_pre.xml EX-101.PRE 11696
17 EXTRACTED XBRL INSTANCE DOCUMENT d14130d8k_htm.xml XML 3865
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 251314962
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)